Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
0.3012
+0.0212 (7.57%)
At close: Feb 25, 2026, 4:00 PM EST
0.3078
+0.0066 (2.19%)
After-hours: Feb 25, 2026, 5:37 PM EST
Plus Therapeutics Employees
Plus Therapeutics had 21 employees as of December 31, 2024. The number of employees increased by 1 or 5.00% compared to the previous year.
Employees
21
Change (1Y)
1
Growth (1Y)
5.00%
Revenue / Employee
$250,381
Profits / Employee
-$979,810
Market Cap
53.28M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 21 | 1 | 5.00% |
| Dec 31, 2023 | 20 | 3 | 17.65% |
| Dec 31, 2022 | 17 | 3 | 21.43% |
| Dec 31, 2021 | 14 | 2 | 16.67% |
| Dec 31, 2020 | 12 | 0 | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Acrivon Therapeutics | 78 |
| Kezar Life Sciences | 55 |
| NextCure | 43 |
| BeyondSpring | 40 |
| LeonaBio | 26 |
| MiNK Therapeutics | 23 |
| Lipocine | 16 |
| Nutriband | 13 |
PSTV News
- 10 hours ago - Plus Therapeutics Announces New Category III CPT Code for Convection-Enhanced Delivery Used with REYOBIQ™ - GlobeNewsWire
- 4 weeks ago - Plus Therapeutics, Inc. (PSTV) Discusses Business Update, REYOBIQ Clinical Program Progress, and Recent Financial Offering Transcript - Seeking Alpha
- 5 weeks ago - Plus Therapeutics to Provide Business Update and Host Conference Call on Thursday, January 22, 2026 at 9:00 A.M. ET - GlobeNewsWire
- 6 weeks ago - Penny Cancer Stock Plus Therapeutics Raises $15 Million At Discount, Stock Plunges - Benzinga
- 6 weeks ago - Plus Therapeutics Announces Pricing of Upsized $15 Million Public Offering - GlobeNewsWire
- 6 weeks ago - Plus Therapeutics Announces Read Out of Type B Meeting with the FDA with Goal of Accelerating Approval of REYOBIQ™ for Leptomeningeal Metastases - GlobeNewsWire
- 2 months ago - Plus Therapeutics Expands CNSide Assay Platform to State of California - GlobeNewsWire
- 2 months ago - Plus Therapeutics Announces Expansion of CNSide Team and Issuance of Inducement Grants - GlobeNewsWire